91 related articles for article (PubMed ID: 29902454)
1. Ataxin-3 promotes testicular cancer cell proliferation by inhibiting anti-oncogene PTEN.
Shi Z; Chen J; Zhang X; Chu J; Han Z; Xu D; Gan S; Pan X; Ye J; Cui X
Biochem Biophys Res Commun; 2018 Sep; 503(1):391-396. PubMed ID: 29902454
[TBL] [Abstract][Full Text] [Related]
2. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
Li Y; Gu J; Lu H
Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
[TBL] [Abstract][Full Text] [Related]
3. Neurodegenerative phosphoprotein signaling landscape in models of SCA3.
Sowa AS; Popova TG; Harmuth T; Weber JJ; Pereira Sena P; Schmidt J; Hübener-Schmid J; Schmidt T
Mol Brain; 2021 Mar; 14(1):57. PubMed ID: 33741019
[TBL] [Abstract][Full Text] [Related]
4. STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells.
Nan H; Han L; Ma J; Yang C; Su R; He J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1684-1692. PubMed ID: 29408595
[TBL] [Abstract][Full Text] [Related]
5. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
6. MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription.
Li Y; Tsang CK; Wang S; Li XX; Yang Y; Fu L; Huang W; Li M; Wang HY; Zheng XF
Hepatology; 2016 Jun; 63(6):1928-42. PubMed ID: 26910647
[TBL] [Abstract][Full Text] [Related]
7. The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells.
Sacco JJ; Yau TY; Darling S; Patel V; Liu H; Urbé S; Clague MJ; Coulson JM
Oncogene; 2014 Aug; 33(33):4265-72. PubMed ID: 24292675
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway.
Li D; Li P; Guo Z; Wang H; Pan W
Int J Mol Med; 2017 Mar; 39(3):757-763. PubMed ID: 28112362
[TBL] [Abstract][Full Text] [Related]
9. Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway.
Guo Y; Chang H; Li J; Xu XY; Shen L; Yu ZB; Liu WC
Apoptosis; 2015 Aug; 20(8):1109-21. PubMed ID: 26002438
[TBL] [Abstract][Full Text] [Related]
10. MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway.
Wu ZH; Lin C; Liu CC; Jiang WW; Huang MZ; Liu X; Guo WJ
Biochem Biophys Res Commun; 2018 Jul; 501(4):1068-1073. PubMed ID: 29777710
[TBL] [Abstract][Full Text] [Related]
11. miR-21 Inhibitors Modulate Biological Functions of Gastric Cancer Cells via PTEN/PI3K/mTOR Pathway.
Wang P; Guan Q; Zhou D; Yu Z; Song Y; Qiu W
DNA Cell Biol; 2018 Jan; 37(1):38-45. PubMed ID: 29185784
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
13. High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling.
Liu L; Hu X; Cai GY; Lv Y; Zhuo L; Gao JJ; Cui SY; Feng Z; Fu B; Chen XM
Nephrol Dial Transplant; 2012 Jan; 27(1):90-100. PubMed ID: 21633095
[TBL] [Abstract][Full Text] [Related]
14. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.
Liu S; Wang XJ; Liu Y; Cui YF
Am J Chin Med; 2013; 41(3):629-42. PubMed ID: 23711146
[TBL] [Abstract][Full Text] [Related]
15. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
[TBL] [Abstract][Full Text] [Related]
16.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
17. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
[TBL] [Abstract][Full Text] [Related]
18. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
Li X; Liu H; Fischhaber PL; Tang TS
Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
[TBL] [Abstract][Full Text] [Related]
19. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
20. miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.
Liu J; Xing Y; Rong L
Oncol Rep; 2018 Apr; 39(4):1631-1639. PubMed ID: 29484437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
